115 related articles for article (PubMed ID: 2454291)
1. Selectivity and stereospecificity of the reactions of dichlorodiammineplatinum(II) with three purified plasma proteins.
Pizzo SV; Swaim MW; Roche PA; Gonias SL
J Inorg Biochem; 1988 May; 33(1):67-76. PubMed ID: 2454291
[TBL] [Abstract][Full Text] [Related]
2. cis-dichlorodiammineplatinum (II) as a selective modifier of the oxidation-sensitive reactive-center methionine in alpha 1-antitrypsin.
Gonias SL; Swaim MW; Massey MF; Pizzo SV
J Biol Chem; 1988 Jan; 263(1):393-7. PubMed ID: 3257210
[TBL] [Abstract][Full Text] [Related]
3. Intersubunit cross-linking by cis-dichlorodiammineplatinum(II) stabilizes an alpha 2-macroglobulin "nascent" state: evidence that thiol ester bond cleavage correlates with receptor recognition site exposure.
Roche PA; Jensen PE; Pizzo SV
Biochemistry; 1988 Jan; 27(2):759-64. PubMed ID: 2450578
[TBL] [Abstract][Full Text] [Related]
4. Evidence that the platinum-reactive methionyl residue of the alpha 2-macroglobulin receptor recognition site is not in the carboxyl-terminal receptor binding domain.
Roche PA; Strickland DK; Enghild JJ; Pizzo SV
J Biol Chem; 1988 May; 263(14):6715-21. PubMed ID: 2452164
[TBL] [Abstract][Full Text] [Related]
5. Further characterization of the platinum-reactive component of the alpha 2-macroglobulin-receptor recognition site.
Pizzo SV; Roche PA; Feldman SR; Gonias SL
Biochem J; 1986 Aug; 238(1):217-25. PubMed ID: 3026342
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of alpha 2-antiplasmin by limited reaction with cis-dichlorodiammineplatinum (II).
Geary WA; Gonias SL
Biochim Biophys Acta; 1989 Jan; 994(1):1-6. PubMed ID: 2521201
[TBL] [Abstract][Full Text] [Related]
7. Altered interaction of Cis-dichlorodiammineplatinum(II)--modified alpha 2-macroglobulin (alpha 2M) with the low density lipoprotein receptor-related protein/alpha 2M receptor but not the alpha 2M signaling receptor.
Howard GC; Misra UK; DeCamp DL; Pizzo SV
J Clin Invest; 1996 Mar; 97(5):1193-203. PubMed ID: 8636430
[TBL] [Abstract][Full Text] [Related]
8. Independent analysis of bait region cleavage dependent and thiolester bond cleavage dependent conformational changes by cross-linking of alpha 2-macroglobulin with cis-dichlorodiammineplatinum(II) and dithiobis(succinimidyl propionate).
Roche PA; Moncino MD; Pizzo SV
Biochemistry; 1989 Sep; 28(19):7629-36. PubMed ID: 2482066
[TBL] [Abstract][Full Text] [Related]
9. Electron microscopy studies of alpha 2-macroglobulin conformational intermediates obtained by derivatization with cis-dichlorodiammineplatinum (II).
Gonias SL; Figler NL
J Biol Chem; 1989 Jun; 264(16):9565-70. PubMed ID: 2470758
[TBL] [Abstract][Full Text] [Related]
10. Concentrations of alpha 1-proteinase inhibitor and alpha 2-macroglobulin in serum and lung secretions of intubated infants.
Bruce MC; Martin RJ; Boat TF
Pediatr Res; 1984 Jan; 18(1):35-40. PubMed ID: 6199725
[TBL] [Abstract][Full Text] [Related]
11. A conserved region in alpha-macroglobulins participates in binding to the mammalian alpha-macroglobulin receptor.
Enghild JJ; Thøgersen IB; Roche PA; Pizzo SV
Biochemistry; 1989 Feb; 28(3):1406-12. PubMed ID: 2469470
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the reactions of platinum antitumor agents with biologic and nonbiologic sulfur-containing nucleophiles.
Dedon PC; Borch RF
Biochem Pharmacol; 1987 Jun; 36(12):1955-64. PubMed ID: 2954556
[TBL] [Abstract][Full Text] [Related]
13. Effect of cis-, trans-diamminedichloroplatinum(II) and DBP on human serum albumin.
Trynda-Lemiesz L; Kozłowski H; Keppler BK
J Inorg Biochem; 1999; 77(3-4):141-6. PubMed ID: 10643655
[TBL] [Abstract][Full Text] [Related]
14. Studies on the interaction between leukocyte elastase, antileukoproteinase and the plasma proteinase inhibitors alpha 1-proteinase inhibitor and alpha 2-macroglobulin.
Fryksmark U; Ohlsson K; Rosengren M; Tegner H
Hoppe Seylers Z Physiol Chem; 1983 Jul; 364(7):793-800. PubMed ID: 6194094
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of the plasma protease inhibitor alpha 2-macroglobulin by the antitumor drug cis-dichlorodiamineplatinum(II).
Gonias SL; Pizzo SV
J Biol Chem; 1981 Dec; 256(23):12478-84. PubMed ID: 6170643
[TBL] [Abstract][Full Text] [Related]
16. The trypsin-inhibitory efficiency of human alpha 2-macroglobulin in the presence of alpha 1-proteinase inhibitor: evidence for the formation of an alpha 2-macroglobulin--alpha 1-proteinase inhibitor complex.
Dejgaard S; Ortapamuk O; Ozer I
J Enzyme Inhib; 1999; 14(5):391-405. PubMed ID: 10488249
[TBL] [Abstract][Full Text] [Related]
17. Multiple and irreversible binding of cis-diamminedichloroplatinum(II) to human serum albumin and its effect on warfarin binding.
Yotsuyanagi T; Ohta N; Futo T; Ito S; Chen DN; Ikeda K
Chem Pharm Bull (Tokyo); 1991 Nov; 39(11):3003-6. PubMed ID: 1799947
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies to DNA modified with cis- or trans-diamminedichloroplatinum(II).
Sundquist WI; Lippard SJ; Stollar BD
Proc Natl Acad Sci U S A; 1987 Dec; 84(23):8225-9. PubMed ID: 2446320
[TBL] [Abstract][Full Text] [Related]
19. Complexes of serum albumin and cis-dichlorodiammineplatinum (II). The role of cysteine 34 as a nucleophilic entering group and evidence for reaction between bound platinum and a second macromolecule.
Gonias SL; Pizzo SV
J Biol Chem; 1983 May; 258(9):5764-9. PubMed ID: 6189837
[No Abstract] [Full Text] [Related]
20. In vivo and in vitro binding of platinum to metallothionein.
Zelazowski AJ; Garvey JS; Hoeschele JD
Arch Biochem Biophys; 1984 Feb; 229(1):246-52. PubMed ID: 6538400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
